Doctor profile · Federal record

Dr. Catherine Millet, P.A.

Physician Assistant · Medical Physician Assistant · Dallas, TX

  • NPI 1740678317
  • Accepts Medicare
  • MIPS 83.3 / 100 · 2023
  • 12 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
8144 Walnut Hill Ln Ste 1300
Dallas, TX 752314365
(214) 420-7070
fax (214) 420-7380
Mailing address
801 York St
Manitowoc, WI 542204630

Credentials & registration

NPPES · NUCC
NPI registered
January 2015 — 11 yrs on file
Profile last updated
June 19, 2024
Year of graduation
2014 — 12 yrs since
Specialty taxonomy
363A00000X — NUCC code
State license (1)
Texas #PA09513

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1740678317. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
2,475
Distinct HCPCS
10
Medicare allowed
$138,953
HCPCS Description Services Patients Avg allowed
17003 Destruction of precancer skin growth, 2-14 growths 749 126 $6
99213 Established patient office or other outpatient visit, 20-29 minutes 457 307 $77
17000 Destruction of precancer skin growth, 1 growth 282 188 $45
99214 Established patient office or other outpatient visit, 30-39 minutes 234 140 $108
11102 Biopsy of related skin growth, first growth 202 151 $77
17110 Destruction of skin growth, 1-14 growths 191 140 $96
96900 Application of ultraviolet light to skin 84 12 $21
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 56 12 $1
11103 Biopsy of related skin growth, each additional growth 45 34 $43
12032 Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm 39 34 $261

In context: peer comparison

Among 190 peers in Dallas Physician Assistant, average services per provider: 90. This provider delivers 28× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$1,824
Transactions
88
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Abbvie INC. 28 $463.03
Dermavant Sciences, INC. 17 $264.42
Genzyme Corporation 10 $244.28
Regeneron Healthcare Solutions, INC. 6 $161.79
Leo Pharma INC. 2 $142.97
Amgen INC. 4 $85.51
Janssen Biotech, INC. 4 $69.92
Lilly USA, LLC 4 $63.93
Novartis Pharmaceuticals Corporation 2 $58.67
Galderma Laboratories, L.P. 3 $52.04
Incyte Corporation 2 $42.45
Arcutis Biotherapeutics, INC. 3 $42.03
Sun Pharmaceutical Industries INC. 1 $26.25
E.R. Squibb & Sons, L.L.C. 1 $24.84
Merz North America, INC. 1 $23.82

By nature of payment

Food and Beverage
$1,816
Education
$8

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
416
Patients
220
Total drug cost
$60,902
Drug Type Claims Patients Total cost
Triamcinolone Acetonide Generic 83 58 $1,009
Clobetasol Propionate Generic 63 29 $4,068
Ketoconazole Generic 63 40 $1,544
Minoxidil Generic 58 16 $808
Hydrocortisone Generic 50 41 $386
Doxycycline Hyclate Generic 33 19 $789
Mupirocin Generic 20 17 $160
Spironolactone Generic 20 0 $1,104
Dupixent Syringe (Dupilumab) Brand 13 0 $50,400
Hydroxychloroquine Sulfate Generic 13 0 $634

Frequently asked questions

Auto-generated from federal data
What is Dr. Catherine Millet's medical specialty?
Dr. Catherine Millet practices Physician Assistant in Dallas, TX.
Where does Dr. Catherine Millet practice?
Dr. Catherine Millet practices at 8144 Walnut Hill Ln Ste 1300, Dallas, TX 752314365. Office phone: 2144207070.
What is Dr. Catherine Millet's NPI?
Dr. Catherine Millet's National Provider Identifier (NPI) is 1740678317, issued by NPPES.
Does Dr. Catherine Millet accept Medicare assignment?
Yes. Dr. Catherine Millet accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Catherine Millet commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.